BAYERI1 Stock Overview
Engages in the pharmaceuticals, consumer health, and crop science businesses in Peru. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Bayer S.A. (Peru) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S/20.00 |
| 52 Week High | S/20.10 |
| 52 Week Low | S/14.50 |
| Beta | 0.099 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 41.84% |
| 3 Year Change | 41.84% |
| 5 Year Change | 42.86% |
| Change since IPO | 315.80% |
Recent News & Updates
Recent updates
Shareholder Returns
| BAYERI1 | PE Pharmaceuticals | PE Market | |
|---|---|---|---|
| 7D | 0% | -7.0% | 0.6% |
| 1Y | 41.8% | -27.5% | 0.8% |
Return vs Industry: BAYERI1 exceeded the PE Pharmaceuticals industry which returned -5.8% over the past year.
Return vs Market: BAYERI1 exceeded the PE Market which returned 10.3% over the past year.
Price Volatility
| BAYERI1 volatility | |
|---|---|
| BAYERI1 Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 2.8% |
| 10% most volatile stocks in PE Market | 6.1% |
| 10% least volatile stocks in PE Market | 1.5% |
Stable Share Price: BAYERI1's share price has been volatile over the past 3 months compared to the PE market.
Volatility Over Time: Insufficient data to determine BAYERI1's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1947 | n/a | Heiko Klaus Mussmann | www.bayer.com/es/co/andina-y-cac-home |
Bayer S.A. (Peru) engages in the pharmaceuticals, consumer health, and crop science businesses in Peru. It operates through three segments: Crop Science, Pharmaceuticals, and Consumer Health. The company offers chemical crop protection products to control weeds; seeds and traits for corn, cotton, soybeans, oilseed rape/canola, rice, wheat, and other crops; biological and chemical products to protect crop plants against fungal diseases; biological and chemical products to protect crop plants from harmful insects and their larvae; vegetable seeds; digital applications for agriculture; products for consumer lawn and garden use and forestry, golf courses, railway tracks and landscape applications; biological and chemical seed treatment products to protect against fungal diseases and pests.
Bayer S.A. (Peru) Fundamentals Summary
| BAYERI1 fundamental statistics | |
|---|---|
| Market cap | S/294.47m |
| Earnings (TTM) | S/11.79m |
| Revenue (TTM) | S/319.14m |
25.0x
P/E Ratio0.9x
P/S RatioIs BAYERI1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BAYERI1 income statement (TTM) | |
|---|---|
| Revenue | S/319.14m |
| Cost of Revenue | S/224.05m |
| Gross Profit | S/95.09m |
| Other Expenses | S/83.30m |
| Earnings | S/11.79m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.80 |
| Gross Margin | 29.79% |
| Net Profit Margin | 3.69% |
| Debt/Equity Ratio | 0% |
How did BAYERI1 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/10/11 21:16 |
| End of Day Share Price | 2024/07/15 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bayer S.A. (Peru) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|